Clinical Trial Update: A Phase 2 Dose-finding Study of Atacicept in Subjects With Rheumatoid Arthritis (AUGUST I) [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 dose-finding study of atacicept in rheumatoid arthritis. The trial, sponsored by EMD Serono, has results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Atacicept (atacicept)

Snippet

Sponsor: EMD Serono | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2016-02-17